1. Home
  2. CSTL vs DADA Comparison

CSTL vs DADA Comparison

Compare CSTL & DADA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • DADA
  • Stock Information
  • Founded
  • CSTL 2007
  • DADA 2014
  • Country
  • CSTL United States
  • DADA China
  • Employees
  • CSTL N/A
  • DADA N/A
  • Industry
  • CSTL Medical Specialities
  • DADA Computer Software: Programming Data Processing
  • Sector
  • CSTL Health Care
  • DADA Technology
  • Exchange
  • CSTL Nasdaq
  • DADA Nasdaq
  • Market Cap
  • CSTL 576.3M
  • DADA 480.6M
  • IPO Year
  • CSTL 2019
  • DADA 2020
  • Fundamental
  • Price
  • CSTL $19.78
  • DADA $1.91
  • Analyst Decision
  • CSTL Strong Buy
  • DADA Hold
  • Analyst Count
  • CSTL 6
  • DADA 3
  • Target Price
  • CSTL $40.00
  • DADA $2.67
  • AVG Volume (30 Days)
  • CSTL 403.1K
  • DADA 1.2M
  • Earning Date
  • CSTL 05-01-2025
  • DADA 03-05-2025
  • Dividend Yield
  • CSTL N/A
  • DADA N/A
  • EPS Growth
  • CSTL N/A
  • DADA N/A
  • EPS
  • CSTL 0.62
  • DADA N/A
  • Revenue
  • CSTL $332,069,000.00
  • DADA $1,323,968,707.00
  • Revenue This Year
  • CSTL N/A
  • DADA $12.63
  • Revenue Next Year
  • CSTL $6.01
  • DADA $12.23
  • P/E Ratio
  • CSTL $32.29
  • DADA N/A
  • Revenue Growth
  • CSTL 51.09
  • DADA N/A
  • 52 Week Low
  • CSTL $16.97
  • DADA $1.04
  • 52 Week High
  • CSTL $35.84
  • DADA $2.52
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 36.62
  • DADA 60.57
  • Support Level
  • CSTL $19.22
  • DADA $1.83
  • Resistance Level
  • CSTL $20.30
  • DADA $1.90
  • Average True Range (ATR)
  • CSTL 0.81
  • DADA 0.02
  • MACD
  • CSTL 0.23
  • DADA -0.01
  • Stochastic Oscillator
  • CSTL 43.33
  • DADA 80.00

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.

About DADA Dada Nexus Limited

Dada Nexus provides on-demand retail platform services and fulfillment services to retailers to sell their products, and online advertising and marketing services to its customers such as brand owners or their agents. It also provides last-mile, intracity and intercity delivery services to logistics companies, merchants and individuals on the Dada Now platform. The group fulfills the delivery needs of retailers on JD Now and customers on Dada Now mostly by utilizing registered riders on Dada Now. Dada's average delivery time for on-demand intracity delivery orders was within 30 minutes in 2023, faster than traditional e-commerce where delivery can take days. As of Sept. 16, 2024, JD.com owned 63.2% of Dada Nexus. Dada Nexus competes with Meituan, Ele.me, Douyin, and SF Intra-city.

Share on Social Networks: